1. Upadhyay, Vaibhav, Yoon, Young Me, Vazquez, Sara E, Sperling, Anne I, Shum, Anthony K. 2024. Phage Immunoprecipitation-Sequencing Reveals CDHR5 Autoantibodies in Select Patients With Interstitial Lung Disease. In ACR open rheumatology, 6, 568-580. doi:10.1002/acr2.11696. https://pubmed.ncbi.nlm.nih.gov/38952015/
2. Gao, Junyi, Wang, Mengyi, Li, Tong, You, Lei, Liao, Quan. 2020. Up-regulation of CDHR5 expression promotes malignant phenotype of pancreatic ductal adenocarcinoma. In Journal of cellular and molecular medicine, 24, 12726-12735. doi:10.1111/jcmm.15856. https://pubmed.ncbi.nlm.nih.gov/33025744/
3. Kim, Bong Jun, Kim, Youngmi, Youn, Dong Hyuk, Kang, Keunsoo, Jeon, Jin Pyeong. 2020. Genome-wide blood DNA methylation analysis in patients with delayed cerebral ischemia after subarachnoid hemorrhage. In Scientific reports, 10, 11419. doi:10.1038/s41598-020-68325-3. https://pubmed.ncbi.nlm.nih.gov/32651463/
4. Wen, Hao, Guo, Qin-Hao, Zhou, Xiao-Lan, Wu, Xiao-Hua, Li, Jin. 2022. Genomic Profiling of Chinese Cervical Cancer Patients Reveals Prevalence of DNA Damage Repair Gene Alterations and Related Hypoxia Feature. In Frontiers in oncology, 11, 792003. doi:10.3389/fonc.2021.792003. https://pubmed.ncbi.nlm.nih.gov/35071000/
5. Bläsius, Felix Marius, Meller, Sebastian, Stephan, Carsten, Tolkach, Yuri, Kristiansen, Glen. 2017. Loss of cadherin related family member 5 (CDHR5) expression in clear cell renal cell carcinoma is a prognostic marker of disease progression. In Oncotarget, 8, 75076-75086. doi:10.18632/oncotarget.20507. https://pubmed.ncbi.nlm.nih.gov/29088846/
6. Klepinowski, Tomasz, Pala, Bartłomiej, Pettersson, Samuel D, Ogilvy, Christopher S, Sagan, Leszek. 2024. Differential DNA methylation associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review. In Neurosurgical review, 47, 144. doi:10.1007/s10143-024-02381-5. https://pubmed.ncbi.nlm.nih.gov/38594575/
智鼠故事 
